Evidence map›Paper›PMID 35063114›Full record

ArticleThe Lancet. Global health2022

Infant deaths from respiratory syncytial virus in Lusaka, Zambia from the ZPRIME study: a 3-year, systematic, post-mortem surveillance project.

Christopher J Gill, Lawrence Mwananyanda, William B MacLeod, Geoffrey Kwenda, Rachel Pieciak, Zachariah Mupila, Caitriona Murphy, Chilufya Chikoti, Leah Forman, Flora Berklein and 12 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Genomic analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Shifts in epidemic patterns and age dynamics of RSV, IFV, and SARS-CoV-2 in Chinese children following COVID-19 non-pharmaceutical intervention relaxation, 2017 - 2024.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Christopher J GillDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA. Electronic address: cgill@bu.edu.
Lawrence MwananyandaDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA; Right to Care Zambia, Lusaka, Zambia.
William B MacLeodDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Geoffrey KwendaDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka, Zambia.
Rachel PieciakDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Zachariah MupilaRight to Care Zambia, Lusaka, Zambia.
Caitriona MurphyRight to Care Zambia, Lusaka, Zambia.
Chilufya ChikotiRight to Care Zambia, Lusaka, Zambia.
Leah FormanBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.
Flora BerkleinBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.
Rotem LapidotDepartment of Pediatrics, Boston University School of Medicine, Boston, MA, USA.
Charles ChimogaRight to Care Zambia, Lusaka, Zambia.
Benard NgomaRight to Care Zambia, Lusaka, Zambia.
Anna LarsonDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
James LunguRight to Care Zambia, Lusaka, Zambia.
Ruth NakazweRight to Care Zambia, Lusaka, Zambia.
Diana NzaraRight to Care Zambia, Lusaka, Zambia.
Lillian PembaRight to Care Zambia, Lusaka, Zambia.
Baron YankondeRight to Care Zambia, Lusaka, Zambia.
Angel ChirwaDepartment of Psychiatry, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.
Magda MwaleRight to Care Zambia, Lusaka, Zambia.
Donald M TheaDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Right to Care · ZMBoston University · USUniversity of Zambia · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections and a key driver of childhood mortality. Previous RSV burden of disease estimates used hospital-based surveillance data and modelled, rather than directly measured, community deaths. Given this uncertainty, we conducted a 3-year post-mortem prevalence study among young infants at a busy morgue in Lusaka, Zambia-the Zambia Pertussis RSV Infant Mortality Estimation (ZPRIME) study.

methodsInfants were eligible for inclusion if they were aged between 4 days and less than 6 months and were enrolled within 48 h of death. Enrolment occurred mainly at the University Teaching Hospital of the University of Zambia Medical School (Lusaka, Zambia), the largest teaching hospital in Zambia. We extracted demographic and clinical data from medical charts and official death certificates, and we conducted verbal autopsies with the guardian or next of kin. RSV was identified using reverse transcriptase quantitative PCR and stratified by age, time of year, and setting (community vs facility deaths). By combining the PCR prevalence data with syndromic presentation, we estimated the proportion of all infant deaths that were due to RSV.

findingsThe ZPRIME study ran from Aug 31, 2017, to Aug 31, 2020, except for from April 1 to May 6, 2020, during which data were not collected due to restrictions on human research at this time (linked to COVID-19). We enrolled 2286 deceased infants, representing 79% of total infant deaths in Lusaka. RSV was detected in 162 (7%) of 2286 deceased infants. RSV was detected in 102 (9%) of 1176 community deaths, compared with 10 (4%) of 236 early facility deaths (<48 h from admission) and 36 (5%) of 737 late facility deaths (≥48 h from admission). RSV deaths were concentrated in infants younger than 3 months (116 [72%] of 162 infants), and were clustered in the first half of each year and in the poorest and most densely populated Lusaka townships. RSV caused at least 2·8% (95% CI 1·0-4·6) of all infant deaths and 4·7% (1·3-8·1) of community deaths.

interpretationRSV was a major seasonal cause of overall infant mortality, particularly among infants younger than 3 months of age. Because most RSV deaths occurred in the community and would have been missed through hospital-based surveillance, the global burden of fatal RSV has probably been underestimated.

fundingBill & Melinda Gates Foundation.

Indexed as

FemaleHumansInfantInfant, NewbornMalePublic Health SurveillanceRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsReverse Transcriptase Polymerase Chain ReactionZambia

Identifiers

PMID35063114
PMCPMC8789563
OpenAlexW4205382675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.